Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin

NCT02104843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Daclatasvir, Asunaprevir and BMS-791325 FDC
DRUG: BMS-791325
DRUG: Rosuvastatin

Sponsor

Bristol-Myers Squibb